Marshall Wace
LFCR icon

Marshall Wace’s Lifecore Biomedical LFCR Stock Holding History

Marshall Wace’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
58,354
-52,267
-47% -$361K ﹤0.01% 2765
2025
Q4 		$905K Sell
110,621
-3,454
-3% -$25.6K ﹤0.01% 1988
2025
Q3 		$840K Buy
114,075
+78,723
+223% +$596K ﹤0.01% 2016
2025
Q2 		$287K Sell
35,352
-32,468
-48% -$219K ﹤0.01% 2340
2025
Q1 		$477K Sell
67,820
-65,371
-49% -$406K ﹤0.01% 2095
2024
Q4 		$990K Sell
133,191
-67,509
-34% -$431K ﹤0.01% 1745
2024
Q3 		$989K Sell
200,700
-99,420
-33% -$519K ﹤0.01% 1653
2024
Q2 		$1.54M Buy
300,120
+139,887
+87% +$828K ﹤0.01% 1486
2024
Q1 		$851K Buy
160,233
+16,340
+11% +$117K ﹤0.01% 1722
2023
Q4 		$891K Buy
143,893
+54,263
+61% +$377K ﹤0.01% 1514
2023
Q3 		$676K Sell
89,630
-37,437
-29% -$342K ﹤0.01% 1625
2023
Q2 		$1.23M Buy
+127,067
New +$776K ﹤0.01% 1631
2022
Q1 		– Sell
-104
Closed -$1K – 3749
2021
Q4 		$1K Buy
+104
New +$1.01K ﹤0.01% 3796

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return